FIELD: chemistry.
SUBSTANCE: invention relates to use of the Lactobacillus paracasei CNCM I-2116 strain to treat irritable bowel syndrome. A probiotic includes dead Lactobacillus paracasei CNCM I-2116 bacteria, a fermentation substrate and/or material made from Lactobacillus paracasei CNCM I-2116.
EFFECT: invention provides the capacity to normalise post-infection hyper-contractible state of intestinal muscles.
2 cl, 4 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PROBIOTICS FOR INTESTINE NEUROMUSCULAR FUNCTION | 2003 |
|
RU2346036C2 |
NON-REPLICATING PROBIOTIC MICROORGANISMS PROTECTING AGAINST INFECTIONS OF UPPER AIRWAY | 2011 |
|
RU2589706C2 |
NON-REPLICATING PROBIOTIC MICROORGANISMS PROTECTING CHILDREN FROM GASTROINTESTINAL INFECTIONS | 2011 |
|
RU2568830C2 |
SYNBIOTIC MIXTURE | 2007 |
|
RU2448720C2 |
BABY PORRIDGES CONTAINING NON-REPLICATING PROBIOTIC MICROORGANISMS | 2010 |
|
RU2549934C2 |
PROBIOTIC COMPOSITION CONTAINING STRAINS OF LACTOBACILLUS RHAMNOSUS AND LACTOBACILLUS PARACASEI | 2016 |
|
RU2744271C2 |
BABY MIXTURE CONTAINING PROBIOTICS | 2006 |
|
RU2428886C2 |
DOMESTIC ANIMAL FODDERS CONTAINING PROBIOTIC MICROORGANISMS | 2011 |
|
RU2580881C2 |
EXTRUDED NON-REPLICATING PROBIOTIC MICROORGANISMS AND APPLICATION THEREOF FOR HEALTH | 2011 |
|
RU2583692C2 |
PREVENTION AND TREATMENT OF ALLERGIC DIARRHOEA | 2010 |
|
RU2522240C2 |
Authors
Dates
2013-08-20—Published
2003-07-23—Filed